TherapeuticsMD, Inc. (TXMD) has 107 open-market insider trades by 23 insiders since 2013. The most active filer is Robert G. Finizio, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Robert G. Finizio | CEO | — | 15 | $15.2M | 2021-05-11 |
| Brian Bernick | Dir | — | 13 | $13.3M | 2022-12-09 |
| John C.k. Milligan IV | PresSecretary | — | 13 | $12.6M | 2021-05-11 |
| Cooper C. Collins | Dir | — | 9 | $6.3M | 2025-02-18 |
| David Efraim Rosen | 10% Owner | — | 4 | $3.8M | 2023-11-15 |
| Nicholas Segal | Dir | — | 2 | $1.6M | 2014-03-26 |
| Mitchell Krassan | CSO | — | 2 | $1.1M | 2020-02-03 |
| Angus C. Russell | Dir | — | 4 | $423K | 2022-08-18 |
| Daniel A. Cartwright | CFO | — | 2 | $377K | 2018-12-06 |
| Tommy G. Thompson | Dir | — | 14 | $333K | 2025-12-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Tommy G. Thompson | Director | Buy | $14K | 2025-12-23 |
| Tommy G. Thompson | Director | Buy | $325 | 2025-04-14 |
| Marlan D. Walker | CEO | Buy | $490 | 2025-04-14 |
| Marlan D. Walker | CEO | Buy | $2K | 2025-04-09 |
| Cooper C. Collins | Director | Buy | $7K | 2024-08-22 |
| Cooper C. Collins | Director | Buy | $2K | 2024-08-21 |
Companies that share insiders with TXMD, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Marlan D. Walker | CEO | Sell | $44K | 2023-12-06 |
| Marlan D. Walker | CEO | Sell | $3K | 2023-04-26 |
| Marlan D. Walker | CEO | Sell | $4K | 2023-04-12 |
| Michael C. Donegan | Prin. Fin. and Acctg. Officer | Sell | $9K | 2023-01-26 |
| Michael C. Donegan | Prin. Fin. and Acctg. Officer | Sell | $7K | 2023-01-23 |
| Rubric Capital Management LP | 10% Owner | Sell | $39K | 2022-12-30 |
| Rubric Capital Management LP | 10% Owner | Buy | $181K | 2022-12-09 |
| Gail K. Naughton | Director | Sell | $21K | 2022-12-07 |
| David Efraim Rosen | 10% Owner | Buy | $229K | 2022-12-07 |